Cited by 589Dementia and Cognitive Impairment ResearchChild Abuse and TraumaPharmaceutical Practices and Patient Outcomes

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

Open access

Abstract

Background: Little information is available in Canada about the prevalence of and outcomes associated with a history of slapping and spanking in childhood. The objectives of this study were to estimate the prevalence of a history of slapping or spanking in a general population sample and to assess the relation between such a history and the lifetime prevalence of psychiatric disorders. Methods: In this general population survey, a probability sample of 9953 residents of Ontario aged 15 years and older who participated in the Ontario Health Supplement was used to examine the prevalence of a history of slapping and spanking. A subgroup of this sample (n = 4888), which comprised people aged 15 to 64 years who did not report a history of physical or sexual abuse during childhood, was used to assess the relation between a history of slapping or spanking and the lifetime prevalence of 4 categories of psychiatric disorder. The measures included a self-administered questionnaire with a question about frequency of slapping and spanking during childhood, as well as an interviewer-administered questionnaire to measure psychiatric disorder. Results: The majority of respondents indicated that they had been slapped or spanked, or both, by an adult during childhood "sometimes" (33.4%) or "rarely" (40.9%); 5.5% reported that this occurred "often." The remainder (20.2%) reported "never" experiencing these behaviours. Among the respondents without a history of physical or sexual abuse during childhood, those who reported being slapped or spanked "often" or "sometimes" had significantly higher lifetime rates of anxiety disorders (adjusted odds ratio [OR] 1.43, 95% confidence interval [CI] 1.04-1.96), alcohol abuse or dependence (adjusted OR 2.02, 95% CI 1.27-3.21) and one or more externalizing problems (adjusted OR 2.08, 95% CI 1.36-3.16), compared with those who reported "never" being slapped or spanked. There was also an association between a history of slapping or spanking and major depression, but it was not statistically significant (adjusted OR 1.64, 95% CI 0.96-2.80). Interpretation: There appears to be a linear association between the frequency of slapping and spanking during childhood and a lifetime prevalence of anxiety disorder, alcohol abuse or dependence and externalizing problems.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.38740.439664.de

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several investigators have reported that anticholinergic medications may be associated with increased risk for sustained cognitive deficits such as mild cognitive impairment or dementia.

    “However, several investigators have reported that anticholinergic medications may be associated with increased risk for sustained cognitive deficits such as mild cognitive impairment or dementia.1,2,14”

    From Cumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study (2015) · cites this paper as [2]

    The Discussion reports that elderly anticholinergic-drug users were more likely to have mild cognitive impairment. However, the Development of dementia section reports no difference in dementia rates at eight years (16% versus 14%), so the dementia part of the claim is not supported by this paper. (LLM, conf=0.89)

    Experimental — accuracy not yet measured
  • Previous longitudinal cohort studies indicate that anticholinergic medications negatively affect cognitive performance.

    “This association between anticholinergic antidepressants and dementia aligns with previous longitudinal cohort studies indicating that anticholinergic medications negatively affect cognitive performance [15, 31, 32, 43, 44].”
  • Observational studies of anticholinergic drugs and dementia risk have generally been relatively small, only assessed short-term exposure, or were subject to recall bias.

    “Observational studies of anticholinergic drugs and dementia risk7,8,9,10 have generally been relatively small, only assessed short-term exposure, or were subject to recall bias.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 24

  1. International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-6.
  2. Ritchie K. Mild cognitive impairment: an epidemiological perspective. Dialogues Clin Neurosci 2004;6:333-40.
  3. Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G, et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996;46:661-5.
  4. Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001;56:37-42.
  5. Fisk JD, Merry HR, Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology 2003;61:1179-84.
  6. Sperling R, Greve D, Dale A, Killiany R, Holmes J, Rosas HD, et al. Functional MRI detection of pharmacologically induced memory impairment. Proc Natl Acad Sci U S A 2002;99:455-60.
  7. Flicker C, Serby M, Ferris SH. Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed. Psychopharmacology (Berl) 1990;100:243-50.
  8. Flicker C, Ferris SH, Serby M. Hypersensitivity to scopolamine in the elderly. Psychopharmacology (Berl) 1992;107:437-41.
  9. Drachman DA, Noffsinger D, Sahakian BJ, Kurdziel S, Fleming P. Aging, memory, and the cholinergic system: a study of dichotic listening. Neurobiol Aging 1980;1:39-43.
  10. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993;3:335-48.
  11. Blazer DG 2nd, Federspiel CF, Ray WA, Schaffner W. The risk of anticholinergic toxic- ity in the elderly: a study of prescribing practices in two populations. J Gerontol 1983;38:31-5.
  12. Mulsant BH, Pollock BG, Kirshner M, Shen C, Dodge H, Ganguli M. Serum anticholin- ergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 2003;60:198-203.
  13. Remillard AJ. A pharmacoepidemiological evaluation of anticholinergic prescribing patterns in the elderly. Pharmacoepidemiol Drug Saf 1996;5:155-64.
  14. Mintzer J, Burns A. Anticholinergic side-effects of drugs in elderly people. J R Soc Med 2000;93:457-62.
  15. Ritchie K, Ledesert B, Touchon J. The Eugeria study of cognitive ageing: who are the 'normal' elderly? Int J Geriatr Psychiatry 1993;8:969-77.
  16. Tune L, Carr S, Hoag E, Cooper T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychia- try 1992;149:1393-4.
  17. Aizenberg D, Sigler M, Weizman A, Barak Y. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr 2002;14:307-10.
  18. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999;15:15-28.
  19. Doniger S, Hofmann T, Yeh J. Predicting CNS permeability of drug molecules: comparison of neural network and support vector machine algorithms. J Comput Biol 2002;9:849-64.
  20. Sippl W. Computational approaches for the prediction of blood-brain barrier permea- tion. Curr Med Chem-Central Nervous System Agents 2002;2:211-27.
  21. Ritchie K, Allard M, Huppert F, Nargeot C, Pinek B, Ledesert B. Computerized cogni- tive examination of the elderly (ECO): the development of a neuropsychological examination for clinic and population use. Int J Geriatr Psychiatry 1993;8:899-914.
  22. Pekkonen E, Jaaskelainen IP, Kaakkola S, Ahveninen J. Cholinergic modulation of preattentive auditory processing in aging. Neuroimage 2005;27:387-92.
  23. Tervo S, Kivipelto M, Hanninen T, Vanhanen M, Hallikainen M, Mannermaa A, et al. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 2004;17:196-203.
  24. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, et al. Prevalence and classification of mild cognitive impairment in the cardiovascular health study cog- nition study: part 1. Arch Neurol 2003;60:1385-9. (Accepted 17 November 2005) doi 10.1136/bmj.38740.439664. · DOI

Cited by

Sorted by citations

Authors
Ancelin, M. L., Artero, S., Portet, F., Dupuy, A.-M., Touchon, J., & Ritchie, K.
Affiliations
Inserm (FR)
Corresponding author
Ritchie, Karen
Venue
BMJ
Publisher
BMJ
Published
2006-02-01
Volume
332
Issue
7539
Pages
455-459
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2044589919
Cited by
589
References
3
Citations by year
2026: 15 · 2025: 13 · 2024: 25 · 2023: 21 · 2022: 21 · 2021: 33 · 2020: 42 · 2019: 39 · 2018: 27 · 2017: 30 · 2016: 30 · 2015: 40 · 2014: 29 · 2013: 20 · 2012: 25
FWCI
21.73
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Fondation de France
  • Conservatoire National des Arts et Métiers
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Psychology › Clinical Psychology › Child Abuse and Trauma
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
older adults, anticholinergic agents, cognitive decline, drug use
MeSH terms
Aged, Aged, 80 and over, Attention, Cognition Disorders, Dementia, Epidemiologic Methods, France, Humans, Language Disorders, Memory Disorders, Middle Aged, Neuropsychological Tests, Reaction Time, Space Perception, Thinking, Cholinergic Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review